Rewind to the future.

ReWing is at the forefront of next generation REHABILITATION bringing together AI and ROBOTICS to drastically improve PEOPLE LIVES.

Contact us Learn more

ReWing is a spin-off company of Istituto Italiano di Tecnologia devoted to the design and development of innovative technologies for sensorimotor rehabilitation in patients with orthopedic and neurological impairments.

ReWing aims to be the technological leader for upper limb robotic rehabilitation, offering to healthcare professionals and patients the tools for the best recovery path possible.

The problem.

More than 150 MILLION people worldwide with MOTOR IMPAIRMENTS. These severely affect DAILY LIFE ACTIVITIES.

Our Solution

ReWing Approach.

We apply the most recent scientific evidences to our devices mixing robotics, artificial intelligence, virtual reality and gamification to provide to clinicians and patients new tools for intense and engaging rehabilitation path.

Contact us

ReWing solution features.


Intensity of Therapy

Reduction of time spent idle and high number of repetitions


Standardization & Repeatability

Objective and quantitative measures


AI-based Assistance

Enhanced recovery trend thanks to automatic adaptive assistance


Effort Reduction

Reduction of cognitive and physical effort of the therapist

... ... ...

Rewing AI: more data better decisions.

ReWing AI enables clinicians and patients to monitor performances adopting ReWing technology and connects our product portfolio across the entire continuum of care.

Reporting and big data

Data driven treatment

Data driven prevention

Device Connectivity

Use cases

ReWing devices can be applied to a variety of conditions.



Traumatic Brain Injury

Traumatic Brain Injury

Spinal Cord Injury

Spinal Cord Injury

Orthopedic Injury

Orthopedic Injury

Cerebral Palsy

Cerebral Palsy

Multiple Sclerosis

Multiple Sclerosis

We are not alone

Scientific Collaborations and Validation

ReWing technologies have been tested by leading research and medical centers worldwide, including adult and pediatric patients, acute, subacute and chronic phases of recovery, severe, moderate and mild levels of impairment.


20+ Journal Papers

30+ Conference Papers

7+ Clinical Studies


500+ Healthy subjects tested

250+ Patients tested